PTIX Insider Trading
Protagenic Therapeutics, Inc.new | Pharmaceutical Preparations
Comprehensive Trading Performance Summary
The investment history of corporate insiders at Protagenic Therapeutics, Inc.new provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2023-10-13 19:48 | 2023-10-12 | Arrow Alexander K. | Officer - Chief Financial Officer | BUY | $0.81 | 8,000 | $6,480 | 45,815 | +21.2% |
| 2022-05-19 00:11 | 2022-05-17 | Arrow Alexander K. | Officer - Chief Financial Officer | BUY | $0.71 | 31,000 | $22,091 | 151,260 | +25.8% |
| 2021-05-03 23:15 | 2021-04-29 | Arrow Alexander K. | Officer - Chief Financial Officer | BUY | $2.29 | 2,000 | $4,580 | 120,260 | +1.7% |
| 2013-11-22 01:05 | 2013-11-08 | QUAKER CAPITAL MANAGEMENT CORP | 10% owner | SELL | $2.68 | 246,700 | $660,761 | 947,415 | -20.7% |
| 2013-10-03 23:02 | 2013-10-01 | QUAKER CAPITAL MANAGEMENT CORP | 10% owner | SELL | $2.78 | 100,000 | $278,120 | 1,194,115 | -7.7% |
| 2013-07-01 23:05 | 2013-06-28 | QUAKER CAPITAL MANAGEMENT CORP | 10% owner | SELL | $1.25 | 100,000 | $125,000 | 1,294,115 | -7.2% |
| 2012-02-25 00:32 | 2012-02-22 | QUAKER CAPITAL MANAGEMENT CORP | 10% owner | SELL | $2.00 | 100,000 | $200,000 | 1,394,115 | -6.7% |
| 2011-05-11 18:20 | 2011-05-09 | QUAKER CAPITAL MANAGEMENT CORP | 10% owner | SELL | $2.24 | 100,000 | $224,240 | 1,494,115 | -6.3% |
| 2010-06-10 17:06 | 2010-06-01 | TILLMAN ROBERT L | Director | BUY | $2.61 | 6,000 | $15,660 | 25,000 | +31.6% |
| 2009-02-18 23:27 | 2009-02-17 | QUAKER CAPITAL MANAGEMENT CORP | 10% owner | SELL | $3.15 | 100,000 | $315,000 | 1,594,115 | -5.9% |
| 2008-08-26 21:45 | 2008-08-22 | MAGINNESS CHARLES E | Director | BUY | $4.55 | 100 | $455 | 601,242 | +0.0% |
| 2008-05-08 23:30 | 2008-05-06 | QUAKER CAPITAL MANAGEMENT CORP | 10% owner | BUY | $4.65 | 273,700 | $1,272,705 | 1,694,115 | +19.3% |
| 2008-04-29 23:53 | 2008-04-25 | QUAKER CAPITAL MANAGEMENT CORP | 10% owner | BUY | $4.54 | 62,771 | $285,213 | 1,420,415 | +4.6% |
| 2008-04-16 17:27 | 2008-04-15 | LAMB DORRANCE W | Officer - Senior VP and CFO | OPT+S | $4.58 | 25,000 | $114,620 | 40,668 | 0.0% |
| 2008-03-05 22:44 | 2008-03-05 | PETERS JOHN J | Officer - SVP Engineering and CTO | OPT+S | $4.53 | 25,000 | $113,368 | 2,302 | 0.0% |
| 2008-03-01 00:11 | 2008-02-27 | QUAKER CAPITAL MANAGEMENT CORP | 10% owner | BUY | $4.74 | 68,344 | $324,197 | 1,357,644 | +5.3% |
| 2008-02-21 00:08 | 2008-02-15 | QUAKER CAPITAL MANAGEMENT CORP | 10% owner | BUY | $4.85 | 28,700 | $139,057 | 1,289,300 | +2.3% |
| 2008-01-31 00:24 | 2008-01-24 | QUAKER CAPITAL MANAGEMENT CORP | 10% owner | BUY | $4.84 | 79,900 | $386,524 | 1,260,600 | +6.8% |
| 2006-08-16 21:07 | 2006-08-16 | SLUSSER JOHN M | Director, Other | SELL | $6.25 | 5,000 | $31,255 | 228,261 | -2.1% |
| 2006-08-15 18:23 | 2006-08-14 | SLUSSER JOHN M | Director, Other | SELL | $6.00 | 4,260 | $25,562 | 233,261 | -1.8% |
| 2006-08-11 21:50 | 2006-08-10 | SLUSSER JOHN M | Director, Other | SELL | $6.12 | 15,740 | $96,300 | 237,521 | -6.2% |
| 2006-05-03 21:52 | 2006-05-03 | SLUSSER JOHN M | Director, Other | SELL | $7.05 | 40,000 | $282,000 | 260,761 | -13.3% |
| 2006-03-21 19:16 | 2006-03-20 | PETERS JOHN J | Officer - Sr. VP Platform Eng. and CTO | OPT+S | $6.80 | 10,000 | $68,000 | 2,302 | 0.0% |
| 2006-03-21 19:08 | 2006-03-20 | GRANA JOHN J | Officer - Sr. VP Systems Engineering | OPT+S | $6.80 | 11,250 | $76,500 | 2,300 | 0.0% |
| 2006-03-01 18:50 | 2006-02-27 | SLUSSER JOHN M | Director, Other | SELL | $7.69 | 5,000 | $38,425 | 300,761 | -1.6% |
| 2006-02-21 18:22 | 2006-02-16 | SLUSSER JOHN M | Director, Other | SELL | $7.00 | 10,000 | $70,000 | 305,761 | -3.2% |
| 2005-12-03 00:48 | 2005-12-01 | TURRELL DONALD L | Director | OPT+S | $9.50 | 2,000 | $19,000 | 50,154 | 0.0% |
| 2005-11-21 18:00 | 2005-11-18 | PETERS JOHN J | Officer - VP Engineering - Hardware | OPT+S | $9.75 | 7,550 | $73,613 | 2,302 | 0.0% |
| 2005-11-18 17:27 | 2005-11-17 | GRANA JOHN J | Officer - VP Engineering - Software | OPT+S | $9.50 | 10,000 | $95,000 | 2,300 | 0.0% |
| 2005-11-18 00:30 | 2005-11-16 | LAMB DORRANCE W | Officer - VP Finance and CFO | OPT+S | $9.20 | 14,723 | $135,456 | 49,316 | 0.0% |
| 2005-11-16 21:41 | 2005-11-16 | GRANA JOHN J | Officer - VP Engineering - Software | OPT+S | $9.25 | 11,250 | $104,063 | 2,300 | 0.0% |
| 2005-11-16 22:46 | 2005-11-15 | TURRELL DONALD L | Director | OPT+S | $8.83 | 32,100 | $283,462 | 42,502 | 0.0% |
| 2005-11-15 22:58 | 2005-11-15 | GRANA JOHN J | Officer - VP Engineering - Software | OPT+S | $8.75 | 11,250 | $98,438 | 2,300 | 0.0% |
| 2005-11-03 17:06 | 2005-11-02 | TURRELL DONALD L | Director, Officer - President and CEO | OPT+S | $8.00 | 25,000 | $200,063 | 44,002 | 0.0% |
| 2005-11-01 00:38 | 2005-10-28 | GRANA JOHN J | Officer - VP Engineering - Software | OPT+S | $8.10 | 32,500 | $263,127 | 2,300 | 0.0% |
| 2005-10-11 18:02 | 2005-10-07 | TURRELL DONALD L | Director, Officer - President and CEO | OPT+S | $7.50 | 25,000 | $187,548 | 44,002 | 0.0% |
| 2005-05-19 22:44 | 2005-05-19 | TILLMAN ROBERT L | Director | BUY | $5.90 | 6,433 | $37,955 | 19,000 | +51.2% |
| 2005-05-19 16:13 | 2005-05-17 | TILLMAN ROBERT L | Director | BUY | $5.59 | 900 | $5,031 | 12,567 | +7.7% |
| 2005-05-04 21:10 | 2005-05-03 | MAGINNESS CHARLES E | Director | BUY | $5.05 | 16,282 | $82,224 | 614,142 | +2.7% |
| 2005-02-22 22:27 | 2005-02-22 | SLUSSER JOHN M | Director, Officer - Chrm Board/Chief Strategic Of | OPT+S | $9.33 | 63,333 | $590,770 | 366,261 | 0.0% |
| 2004-08-24 17:38 | 2004-08-23 | KOZEL BERNARD | Director | BUY | $5.84 | 3,800 | $22,210 | 194,144 | +2.0% |
| 2004-08-23 16:58 | 2004-08-19 | KOZEL BERNARD | Director | BUY | $5.90 | 1,200 | $7,080 | 190,344 | +0.6% |
| 2004-08-04 22:37 | 2004-08-04 | LAMB DORRANCE W | Officer - VP Finance and CFO | BUY | $5.85 | 1,000 | $5,850 | 49,316 | +2.1% |
| 2004-03-04 19:19 | 2004-03-03 | MAGINNESS CHARLES E | Director | SELL | $20.02 | 7,600 | $152,137 | 597,860 | -1.3% |
| 2004-03-03 16:52 | 2004-03-02 | MAGINNESS CHARLES E | Director | SELL | $20.00 | 14,900 | $298,000 | 605,460 | -2.4% |
| 2004-02-25 20:50 | 2004-02-24 | MOONEY JOHN E | Director | SELL | $18.01 | 3,000 | $54,019 | 8,295 | -26.6% |
| 2004-02-25 21:13 | 2004-02-17 | MAGINNESS CHARLES E | Director | SELL | $20.01 | 50,000 | $1,000,320 | 620,360 | -7.5% |
| 2004-02-19 20:12 | 2004-02-19 | GRANA JOHN J | Officer - VP Engineering - Software | OPT+S | $20.03 | 10,000 | $200,300 | 2,300 | 0.0% |
| 2004-02-13 21:51 | 2004-02-12 | MAGINNESS CHARLES E | Director | SELL | $21.00 | 2,500 | $52,500 | 670,360 | -0.4% |
| 2004-02-12 16:55 | 2004-02-11 | SLUSSER JOHN M | Director, Officer - Chrm Board/Chief Strategic Off | SELL | $19.72 | 56,250 | $1,109,138 | 366,261 | -13.3% |
How to Interpret $PTIX Trades
Not every insider transaction in Protagenic Therapeutics, Inc.new is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $PTIX shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for PTIX
Insider activity data for Protagenic Therapeutics, Inc.new is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $PTIX, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.